brequinar has been researched along with Thrombopenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armand, JP; Barbu, M; Carde, P; Chabot, GG; de Forni, M; Domenge, C; Fontana, X; Gouyette, A; Recondo, G | 1 |
Donatsch, P; Dorobek, B; Jaffee, B; Magolda, R; Pally, C; Papageorgiou, C; Schuurman, HJ; Smith, D; Zehender, H | 1 |
1 trial(s) available for brequinar and Thrombopenia
Article | Year |
---|---|
Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Biphenyl Compounds; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Half-Life; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Thrombocytopenia | 1993 |
1 other study(ies) available for brequinar and Thrombopenia
Article | Year |
---|---|
Side effects of brequinar and brequinar analogues, in combination with cyclosporine, in the rat.
Topics: Administration, Oral; Animals; Biphenyl Compounds; Blood Cell Count; Body Weight; Bone Marrow; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Immunosuppressive Agents; Jejunum; Leukopenia; Male; Rats; Rats, Inbred Lew; Spleen; Thrombocytopenia; Thymus Gland; Toxicity Tests; Weight Gain | 1998 |